MS progression predictedRSS Feed

Researchers have developed a tool which can forecast the progression of brain and spinal cord injury in multiple sclerosis (MS).

Scientists at Mayo Clinic are now able to predict which patients will experience a faster onset of the condition, according to the research presented at the American Academy of Neurology meeting in Honolulu, Hawaii.

Progressive MS damages the optic nerves and causes spinal cord and brain injury, which can impede the mobility of individuals with the condition.

Lead author Orhun Kantarci explained: "We found that in patients who developed the progressive form of MS that had preceding relapses, the presence of greater production of one of these molecules, immunoglobulin G, predicted a faster onset of disability."

Meanwhile, a study published in the American Academy of Neurology found that stem cells could be used to help slow the progression of MS.

The procedure involved using chemotherapy to kill all of the patient's blood cells. Following this treatment, bone marrow stem cells are purified and transplanted back into the body.

News brought to you by Serious Law specialists in traumatic brain injury

Posted by Timothy Walters
 

Optic inflammation 'needs better therapies'

12 April 2011

Scientists are attempting to develop protection for the optic nerve during traumatic brain injury by studying the nerve's response to such damage.The researchers, from Georgia Health Sciences University,...

Read More...

New findings 'could lead to new Parkinson's treatments'

11 April 2011

New research investigating the role of neurotransmitter dopamine in the brain could lead to treatments for the brain injury seen in neurodegenerative conditions, researchers have claimed.Scientists at...

Read More...

Welding fumes 'linked to brain injury'

08 April 2011

People who are exposed to welding fumes could be at an increased risk of developing brain injury, research has shown.A study, published in journal Neurology, indicated that exposure to welding fumes put...

Read More...